Psychotropic drugs: phenibut now banned because of “serious risks” to health

Psychotropic drugs phenibut now banned because of serious risks to

  • News
  • Published on 09/22/2020


    1 min read

    Dependence, psychiatric disorders, even comas: faced with an increase in the number of intoxications with phenibut, a synthetic psychotropic drug, the ANSM has decided to ban its production, sale and purchase.

    On the internet, it is mainly found in the form of capsules, tablets, capsules or even powder. the phenibut, a synthetic psychotropic drug, is pinned by the National Agency for the Safety of Medicines and Health Products (ANSM): in a press release published on September 16, it announces the prohibition of its production, sale and purchasetaking into account the serious risks to public health”Related to its consumption.

    “False claims” of medication or dietary supplement

    Also known as 4-amino-3-phenylbutanoic acid and used as a medicine or food supplement, phenibut is the subject of “false claims“: Anxiolytic, hypnotic, helps muscle recovery, stimulates sexual performance, natural product to aid withdrawal (alcohol, opiates) … It is actually a”potentially dangerous substance”, Warns the ANSM, which asked the Centers for Assessment and Information on Drug Dependence-Addictovigilance (CEIP-A) to conduct a survey on its use in France, between 2007 and 2019.

    Increase in the number of poisonings

    This study revealed a recent increase in the number of intoxications among users of phenibut (7 cases in 2019 out of a total of 14 reports), note the press release, including cases of dependence, sometimes severe withdrawal syndromes, but also more serious intoxications such as psychiatric disorders or comas. This product is sometimes taken in combination with other psychoactive substances.

    Among the main symptoms observed: vomiting, dizziness, tachycardia, anxiety, insomnia, hallucinations, drowsiness and / or coma. Phenibut is now listed on the list of psychotropic substances developed by the Ministry of Health.

    .

    dts2